Connection

Co-Authors

This is a "connection" page, showing publications co-authored by WENDY WOODWARD and SIMONA F. SHAITELMAN.
Connection Strength

6.085
  1. Neoadjuvant radioimmunotherapy synergy in triple-negative breast cancer: Is microenvironment-guided patient selection on the horizon? Cancer Cell. 2024 01 08; 42(1):10-12.
    View in: PubMed
    Score: 0.968
  2. Impact of Statin Use on Outcomes in Triple Negative Breast Cancer. J Cancer. 2017; 8(11):2026-2032.
    View in: PubMed
    Score: 0.616
  3. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Pract Radiat Oncol. 2023 Oct 31.
    View in: PubMed
    Score: 0.239
  4. Patient Interest in Exploring Nonsurgical Treatment Approaches for Early-Stage Breast Cancer: A Qualitative Study. Int J Radiat Oncol Biol Phys. 2024 Feb 01; 118(2):443-454.
    View in: PubMed
    Score: 0.238
  5. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast. 2023 Apr; 68:205-215.
    View in: PubMed
    Score: 0.228
  6. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat. 2022 Aug; 195(1):33-41.
    View in: PubMed
    Score: 0.218
  7. Locoregional Management and Prognostic Factors in Breast Cancer With Ipsilateral Internal Mammary and Axillary Lymph Node Involvement. Int J Radiat Oncol Biol Phys. 2022 07 01; 113(3):552-560.
    View in: PubMed
    Score: 0.213
  8. Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):426-436.
    View in: PubMed
    Score: 0.207
  9. Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):437-444.
    View in: PubMed
    Score: 0.207
  10. The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):698-712.
    View in: PubMed
    Score: 0.178
  11. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol. 2018 Oct 31; JCO1800317.
    View in: PubMed
    Score: 0.169
  12. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):568-577.
    View in: PubMed
    Score: 0.165
  13. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers (Basel). 2018 Apr 07; 10(4).
    View in: PubMed
    Score: 0.162
  14. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):291-300.
    View in: PubMed
    Score: 0.152
  15. Erratum to: Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017 04; 162(2):217.
    View in: PubMed
    Score: 0.151
  16. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017 04; 162(2):201-215.
    View in: PubMed
    Score: 0.149
  17. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):637-44.
    View in: PubMed
    Score: 0.144
  18. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol. 2015 Oct; 1(7):931-41.
    View in: PubMed
    Score: 0.136
  19. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer. 2015 Dec 15; 121(24):4324-32.
    View in: PubMed
    Score: 0.136
  20. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):102-10.
    View in: PubMed
    Score: 0.133
  21. Proton partial breast irradiation in the supine position: Treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol. 2015 Jul-Aug; 5(4):e283-90.
    View in: PubMed
    Score: 0.131
  22. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus. 2015; 4:36.
    View in: PubMed
    Score: 0.130
  23. Shortened radiation therapy schedules for early-stage breast cancer: a review of hypofractionated whole-breast irradiation and accelerated partial breast irradiation. Breast J. 2014 Mar-Apr; 20(2):131-46.
    View in: PubMed
    Score: 0.122
  24. Inclusion of premenopausal women in breast cancer clinical trials. Breast. 2022 Oct 26; 66:204-207.
    View in: PubMed
    Score: 0.056
  25. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Ann Surg Oncol. 2022 Oct; 29(10):6370-6378.
    View in: PubMed
    Score: 0.055
  26. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol. 2022 Mar-Apr; 7(2):100877.
    View in: PubMed
    Score: 0.053
  27. Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer. 2021 11 15; 127(22):4142-4150.
    View in: PubMed
    Score: 0.051
  28. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):360-370.
    View in: PubMed
    Score: 0.050
  29. Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer. J Surg Oncol. 2021 Mar; 123(4):846-853.
    View in: PubMed
    Score: 0.049
  30. Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):441-448.
    View in: PubMed
    Score: 0.048
  31. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist. 2020 06; 25(6):e990-e992.
    View in: PubMed
    Score: 0.047
  32. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys. 2019 07 01; 104(3):574-581.
    View in: PubMed
    Score: 0.043
  33. Association of Transforming Growth Factor ? Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2018 12 01; 4(12):1751-1757.
    View in: PubMed
    Score: 0.042
  34. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Pract Radiat Oncol. 2019 Jan; 9(1):e4-e13.
    View in: PubMed
    Score: 0.042
  35. A component of lobular carcinoma in clinically lymph node-negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer. Adv Radiat Oncol. 2018 Jul-Sep; 3(3):252-257.
    View in: PubMed
    Score: 0.040
  36. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Res Treat. 2018 Jun; 169(3):615-623.
    View in: PubMed
    Score: 0.040
  37. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol. 2017 Oct; 24(10):2965-2971.
    View in: PubMed
    Score: 0.039
  38. Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer. Cancer. 2017 Jul 15; 123(14):2618-2625.
    View in: PubMed
    Score: 0.038
  39. Longitudinal analysis of patient-reported outcomes and cosmesis in a randomized trial of conventionally fractionated versus hypofractionated whole-breast irradiation. Cancer. 2016 09 15; 122(18):2886-94.
    View in: PubMed
    Score: 0.036
  40. Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly? Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):49-51.
    View in: PubMed
    Score: 0.036
  41. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast?Cancer. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1218-25.
    View in: PubMed
    Score: 0.035
  42. Implementing a Real-Time Electronic Data Capture System to Improve Clinical Documentation in Radiation Oncology. J Am Coll Radiol. 2016 Apr; 13(4):401-7.
    View in: PubMed
    Score: 0.035
  43. Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol. 2014 Aug; 21(8):2468-73.
    View in: PubMed
    Score: 0.031
  44. Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):116-122.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.